Health Policy & RegulationRegulatory

Federal Health Regulatory Update: CMS Releases 2027 Medicare Advantage Ratings and HHS Announces New Grants

Recent regulatory updates from Washington, D.C., highlight a series of federal announcements, funding allocations, and policy changes across the Department of Health and Human Services and the Centers for Medicare & Medicaid Services. These developments span Medicare Advantage quality metrics, falls prevention investments, vaccine safety reporting initiatives, and hospital price transparency compliance.

Medicare Advantage Star Ratings and Federal Funding Initiatives

The Centers for Medicare & Medicaid Services released the 2027 Medicare Advantage star ratings. According to federal data, CMS counted 508 Medicare Advantage Prescription Drug contracts for 2027, yielding an average score of 3.99. This average represents a slight decrease from the 2026 score of 4.01, though it remains higher than the 2025 average of 3.95. Many enrollees remain in plans that achieved a rating of at least four stars.

In separate funding news, the Department of Health and Human Services announced an investment of up to $27.8 million distributed over three years to support three falls prevention initiatives. According to agency statements, the funding aims to expand existing programs, connect healthcare screenings with community-based balance and strength initiatives, and help older adults maintain independence in their communities.

Vaccine Safety, Transparency, and Rural Health Programs

Federal health officials also unveiled new measures concerning vaccine safety reporting and program oversight. The Department of Health and Human Services launched initiatives designed to modernize the Vaccine Adverse Event Reporting System, establish a new National Institutes of Health clinic, require electronic health records to capture vaccine-related adverse events, and propose physician reimbursement for reporting suspected injuries.

Additionally, regulatory agencies addressed pricing transparency and rural healthcare delivery:

  • The Federal Trade Commission issued warning letters to 24 major healthcare systems regarding hospital price transparency compliance for non-emergency, scheduled services.
  • CMS finalized rules intended to make payer and provider data files more usable by removing duplicative information and adding in-network pricing context.
  • North Carolina and South Dakota received substantial funding allocations through the Rural Health Transformation Program to bolster local mental health clinics, opioid use disorder treatments, and emergency medical services.

The White House additionally announced plans to disburse $90 rebates to more than 20 million Medicare Part B enrollees utilizing funds from the Medicare Improvement Fund. Meanwhile, policy heads released a report arguing that the 340B drug pricing program has expanded beyond its original scope, potentially fueling provider consolidation. Federal agencies continue to review and implement these wide-ranging administrative updates.

Source: Fierce Healthcare